|
|
| | (1-(5-fluoro-4-hydroxypentyl)-1H-indol-3-yl-2,4,5,6,7-d5)(naphthalen-1-yl)methanone Basic information |
| | (1-(5-fluoro-4-hydroxypentyl)-1H-indol-3-yl-2,4,5,6,7-d5)(naphthalen-1-yl)methanone Chemical Properties |
| Boiling point | 603.594±50.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.200±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | solubility | Dichloromethane: 20 mg/ml; DMF: 20 mg/ml; DMSO: 20 mg/ml; Ethanol: 5 mg/ml |
| | (1-(5-fluoro-4-hydroxypentyl)-1H-indol-3-yl-2,4,5,6,7-d5)(naphthalen-1-yl)methanone Usage And Synthesis |
| Description | AM2201 N-(4-hydroxypentyl) metabolite-d5 contains five deuterium atoms at the 2, 4, 5, 6, and 7 positions. It is intended for use as an internal standard for the quantification of AM2201 N-(4-hydroxypentyl) metabolite by GC- or LC-mass spectrometry. AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively.1 AM2201 N-(4-hydroxypentyl) metabolite is an expected urinary metabolite of AM2201, based on the known metabolism of similar compounds.2 Its biological actions are unknown. | | References | 1. Makriyannis, A., and Deng, H. Cannabimimetic indole derivatives US7241799B2,(2001). 2. Wintermeyer, A., Mller, I., Thevis, M., et al. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018 Anal. Bioanal. Chem. 398(5),2141-2153(2010). |
| | (1-(5-fluoro-4-hydroxypentyl)-1H-indol-3-yl-2,4,5,6,7-d5)(naphthalen-1-yl)methanone Preparation Products And Raw materials |
|